7Sievert D M, Rudrik J T, Patel J B, et al . Vancomycin-Resistant Staphylococcus aureus in the United States, 2002- 2006[J]. Clin Infect Dis, 2008, 46(5): 668-741.
8Steinkraus G, White R, Friedrich L, et al. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05[J] JAntimicrob Chemother, 2007, 60(4): 788-794.
9Wang G Q, Hindler J F, Ward K W, et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a University Hospital during a 5-Year period[J]. J Clin Microbiol, 2006, 44(11): 3883-3886.
10Lodise T P, Graves J, Evans A, et al. Relationship between Vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bactere-mia treated with vancomycin[J]. Antimicrob Agents Chemother, 2008, 52(9): 3315-3320.